Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas van Groen

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Behavioural Brain Research|August 23, 2002
Effects of fimbria-fornix lesion and amyloid pathology on spatial learning and memory in transgenic APP+PS1 miceLi Liu, Sami Ikonen, Taneli Heikkinen, et al.
Experimental Brain Research|December 6, 2005
Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularisMiroljub Popović, Maria Caballero-Bleda, Natalija Popović, et al.
Neurobiology of Disease|May 12, 2009
Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamusMikko Hiltunen, Petra Mäkinen, Sirpa Peräniemi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 28, 2015
Cyclic Ozone Exposure Induces Gender-Dependent Neuropathology and Memory Decline in an Animal Model of Alzheimer's DiseaseHasina Akhter, Carol Ballinger, Nianjun Liu, et al.
Neuroscience Letters|May 6, 2008
Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathologySaila Vepsäläinen, Mikko Hiltunen, Seppo Helisalmi, et al.
Neurobiology of Disease|April 13, 2002
Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic miceJukka Puoliväli, Jun Wang, Taneli Heikkinen, et al.
Brain Research|October 6, 2007
Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 miceCarlijn R Hooijmans, Coen Graven, Pieter J Dederen, et al.
Journal of Neurosurgery|September 24, 2016
Treatment of traumatic brain injury with 17α-ethinylestradiol-3-sulfate in a rat modelHarrison Kim, Tao Yu, Betul Cam-Etoz, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2018
A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's DiseaseHasina Akhter, Wen-Tan Huang, Thomas van Groen, et al.
Experimental Neurology|June 16, 2012
Tissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's diseaseAshish Kumar, Andrew Kneynsberg, Janusz Tucholski, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Behavioural Brain Research|August 23, 2002
Effects of fimbria-fornix lesion and amyloid pathology on spatial learning and memory in transgenic APP+PS1 miceLi Liu, Sami Ikonen, Taneli Heikkinen, et al.
Experimental Brain Research|December 6, 2005
Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularisMiroljub Popović, Maria Caballero-Bleda, Natalija Popović, et al.
Neurobiology of Disease|May 12, 2009
Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamusMikko Hiltunen, Petra Mäkinen, Sirpa Peräniemi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 28, 2015
Cyclic Ozone Exposure Induces Gender-Dependent Neuropathology and Memory Decline in an Animal Model of Alzheimer's DiseaseHasina Akhter, Carol Ballinger, Nianjun Liu, et al.
Neuroscience Letters|May 6, 2008
Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathologySaila Vepsäläinen, Mikko Hiltunen, Seppo Helisalmi, et al.
Neurobiology of Disease|April 13, 2002
Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic miceJukka Puoliväli, Jun Wang, Taneli Heikkinen, et al.
Brain Research|October 6, 2007
Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 miceCarlijn R Hooijmans, Coen Graven, Pieter J Dederen, et al.
Journal of Neurosurgery|September 24, 2016
Treatment of traumatic brain injury with 17α-ethinylestradiol-3-sulfate in a rat modelHarrison Kim, Tao Yu, Betul Cam-Etoz, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2018
A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's DiseaseHasina Akhter, Wen-Tan Huang, Thomas van Groen, et al.
Experimental Neurology|June 16, 2012
Tissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's diseaseAshish Kumar, Andrew Kneynsberg, Janusz Tucholski, et al.
Pageof 9